May 29, 2024

PRISM NextGen Tech and AI Index Leader, Brand Engagement (BNAI) Up 88% on Private Placement News

Brand Engagement Network Inc. (BNAI), a rising provider of personalized customer engagement AI, today announced the successful closure of a private placement with existing investors, securing $4.95 million through the sale of common stock and warrants. This funding will enhance BEN’s financial flexibility as it advances the development of its human-like, business-safe conversational AI assistants…. [Read More]
May 29, 2024

BranchOut Food Advances Collaboration with U.S. Army with Completed Shelf-Life Test

Shares in food technology company, BranchOut Food (Nasdaq: BOF), climbed on Tuesday morning after the company announced it has successfully completed a six month shelf-life test as part of its strategic collaboration with the U.S. Army Combat Capabilities Development Command (DEVCOM). BranchOut Food is working with DEVCOM to enhance Meals Ready-to-Eat (MREs) utilizing its proprietary… [Read More]
May 29, 2024

Semler Scientific Adopts Bitcoin as Primary Asset

Healthcare technology provider, Semler Scientific, Inc. (Nasdaq: SMLR), has announced that it has adopted bitcoin as its primary treasury reserve asset. The company has purchased 581 bitcoins for an aggregate amount of $40 million, inclusive of fees and expenses. The company’s share price rose 24.35% in trading on Tuesday following the news. “Our bitcoin treasury… [Read More]
May 28, 2024

Digested Read: Breakthroughs from DDW 2024

The human digestive system contains eight organs and has its own nervous system. It can be affected by our emotions and is ruled by a two-way communication network known as the gut-brain axis, a complex network of chemicals, nerve cells, and microbes. Each year, Digestive Disease Week (DDW) brings together professionals working in gastroenterology, hepatology,… [Read More]
May 28, 2024

Rhythm Pharmaceuticals IMCIVREE® for Obesity and Hunger Control Receives NICE Backing

Global biopharmaceutical company, Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), has received a positive recommendation from the National Institute for Health and Care Excellence (NICE) , which has issued guidance for the company’s IMCIVREE® (setmelanotide) as an option for treating obesity and the control of hunger in Bardet-Biedl syndrome (BBS) patients aged 6 years and over. Results… [Read More]
May 28, 2024

CorMedix Inks Commercial Supply Agreement with Top-Tier Dialysis Provider

Shares in biopharmaceutical company, CorMedix (Nasdaq: CRMD), rose in morning trading on Tuesday after the company announced that it has entered into a multi-year commercial supply contract with a top-tier dialysis provider for the supply of DefenCath® (taurolidine and heparin). DefenCath® is the first FDA-approved catheter lock solution (CLS) designed to reduce the incidence of… [Read More]
May 28, 2024

Predictive Oncology (POAI) Announces Positive Results from Recent Study Utilizing AI To Predict Cancer Patient Outcomes, Up ~40%.

The AI driven drug discovery company, Predictive Oncology, Inc. (POAI) announced positive results from a recent study whose purpose was to determine if POAI could utilize its AI capabilities and machine learning (ML) models to more accurately predict short- and long-term survival outcomes amongst ovarian cancer patients. This study was completed in collaboration with UPMC… [Read More]
May 28, 2024

Stocks making the biggest moves premarket: GameStop, Nvidia, Airbnb, Viking and more

Here are some companies grabbing the spotlight before market open. GameStop — The firm’s stock skyrocketed by nearly 27% following its declaration on Friday of having raised approximately $933.4 million through a share offering, where it let go of 45 million common shares. Nvidia — This electronics hardware manufacturer ascended 3% in premarket trading, extending… [Read More]
May 24, 2024

Autonomix Investigates Novel Approach to Treating Pancreatic Cancer

Medical device company, Autonomix Medical, Inc. (Nasdaq: AMIX) has successfully completed an animal study evaluating the ability of targeted nerve ablation to impact tumor metastases and growth. The company’s share price rose on Friday in response to the news. Autonomix is developing its catheter-based sensing technology to address pancreatic cancer-related pain. Current approaches, which primarily… [Read More]
May 24, 2024

This Week’s PRISM Market Recap: The Bull and Bear Report

This week, earnings wrapped up with additional major retail reports and included the highly anticipated NVIDIA (NVDA) announcement while further economic commentary was released. Some normalcy is expected to return next week as companies attend conferences and scheduled macro news slows. Market data and observations are constantly in motion each day, but what dictates the… [Read More]